Friday November 15, 2019
8.30-8.45 Morten Schiodt, Chairman, Copenhagen, Denmark:
Welcome, introduction and news to be presented.
8.45-9.05 Stefano Fedele, London, England:
How do we define and classify MRONJ?
Genetic risk factors for MRONJ.
9.05-9.20 Bente Brokstad Herlufson, Oslo, Norway:
The Scandinavian ONJ Cohort Study.
A 5 year collaborative Study from Denmark, Sweden and Norway.
9.20-9.40 Sven Otto, Munich, Germany:
What is the evidence for infection as a risk factor for MRONJ?
9.40-10.00 Cecilia Larsson Wexell, Gothenborg/Lund, Sweden:
How does MRONJ look in the microscope?
10.00-10.15: Coffee Break
10.15-10.35 Roman Guggenberger, Zurich, Switzerland:
Imaging of MRONJ.
What can be detected from panoramic x-rays?
Value of conebeam computer tomography, CT scans, Scintigraphy and MR scans.
10.35-10.50 Sven Otto, Munich, Germany:
Treatment of MRONJ - 1:
Indications and procedures for minimally invasive surgery for MRONJ.
10.50-11.05 Morten Schiodt, Copenhagen, Denmark:
Treatment of MRONJ – 2:
How to do block resections?
How to do buccal fat pad closure of maxillary defects.
11.05-11.25 Thomas Kofod, Copenhagen, Denmark:
Treatment of MRONJ - 3:
When and how to do continuity resections and major reconstructive surgery of MRONJ?
How to implement computer assisted 3D-planning?
11.25-11.40 Sven Erik Nørholt, Aarhus, Denmark:
Treatment of MRONJ - 4:
Is there a role for platelet rich fibrin (PRF) in the treatment of MRONJ?
11.40-11.55 Oliver Ristow, Heidelberg, Germany:
Treatment of MRONJ - 5:
Strategies for treatment – surgical or non-surgical?
11.55-12.10 Alberto Bedogni, Padova, Italy:
Natural course of MRONJ and factors affecting prognosis. The results of a clinico-radiological (CT) longitudinal cohort study.
13.00-13.15 Vinod Patel, London, England:
Which drugs can cause MRONJ besides bisphosphonate and denusomab?
13.15-13.30 Ourania Nicolatou-Galitis, Athens, Greece:
What is the role of periodontal disease for MRONJ?
13.30-13.45 Morten Schiodt, Copenhagen, Denmark:
When and how to extract teeth during antiresorptive treatment?
Can we control the risk of MRONJ?
13.45-14.00 Sanne Werner Møller Andersen, Copenhagen, Denmark:
Are dental implants safe to use in patients on antiresorptive treatment?
14.00-14.15 Sven Otto, Munich, Germany et al.:
Results from the Copenhagen MRONJ Workshop in 2018.
Current challenges in MRONJ.
14.15-14.35: Coffee break
14.35 -15.00 Morten schioedt, Copenhagen, Denmark:
Guidelines for the dental practitioner:
What is the role of the dentist before and during antiresorptive treatment?
When do you suspect osteonecrosis?
When to refer to hospital or specialized clinic?
15.00-16.00 Cases to solve for the participants:
Group work at the tables.
16.00-16.55 Round table discussion:
Moderator: Morten Schiodt
Alberto Bedogni, Stefano Fedele, Roman Guggenberger, Bente Brokstad Herlofson, Thomas Kofod, Ourania Nicolatou-Galitis, Sven Erik Nørholt, Sven Otto, Vinod Patel, Oliver Ristow, Cecilia Larsson Wexell
Questions from the audience.
16.55-17.00 Morten Schiodt, Copenhagen, Denmark:
Summary and Closing the Symposium.